Aethlon Medical Inc
AEMD
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.49M
Close$
$6.96
137.5% upside
Current Fair Value
137.5% upsideUndervalued by 137.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.49 Million |
|---|---|
| Enterprise Value | $-4,677,036,405.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-10.61 |
| Beta | 1.44 |
| Outstanding Shares | 384,705 |
Return
| Return on Equity | -67.49% |
|---|---|
| Return on Assets | -56.27% |
| Return on Invested Capital | -28.67% |
Valuation & Multiples
| P/E Ratio | -0.24 |
|---|---|
| PEG | 0.24 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 3.14 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | -0.05 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-3.92
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 19, 2026
EPS Estimate
$-0.75
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 4.51%▲ 2.51% |
|---|---|
| Total Invested | $155,016▲ 239.63% |
| Investors Holding | 12▲ 4.00% |
ESG Score
No data
About Aethlon Medical Inc
CEO: Timothy Rodell